Preserving Life: My Journey Beyond Endometrial

A Sudden Diagnosis That Changed Everything

In January 2023, Ms. Liu began experiencing persistent bleeding that she could not explain. When she sought medical attention the following month, the results came as a devastating shock: she was diagnosed with endometrioid carcinoma. At just thirty-nine years old, the diagnosis felt incomprehensible. With no family history of cancer and consistently excellent health throughout her life, Ms. Liu struggled to accept her new reality.

Determined to explore her options, she visited multiple hospitals across Malaysia. Each physician delivered the same recommendation: surgical removal of the uterus was the standard treatment protocol. However, Ms. Liu felt an immediate resistance to this approach. “I was still young and needed my uterus not only for my physical health, but also for my psychological well-being,” she recalls. Rather than accepting this as her only choice, she embarked on an intensive research journey, spending countless hours reading medical articles, investigating alternative approaches, and investigating specialized cancer centers worldwide.

The Discovery of Hope: Minimally Invasive Alternatives

During her research, Ms. Liu discovered information about minimally invasive tumor treatment techniques that could potentially address her condition without requiring surgical removal of the uterus. She learned that St. Stamford Modern Cancer Hospital Guangzhou had extensive experience and proven success with these advanced approaches. This discovery rekindled her hope. With the full encouragement and support of her family, she made the decision to travel internationally for treatment. “I always believed that there would be a suitable treatment path for my specific situation,” she reflects, emphasizing her unwavering determination.

Understanding the Treatment Strategy

On April 3, 2023, Ms. Liu arrived at the hospital for a comprehensive re-evaluation. The medical team performed detailed imaging studies that revealed the full extent of her disease: two distinct tumors occupied her uterus, with the larger measuring approximately 13x11x10 centimeters and the smaller roughly 7x7x8 centimeters. Additionally, the imaging showed that cancer had spread to lymph nodes in her abdomen and to her liver, confirming a diagnosis of stage IV endometrial cancer. The substantial abdominal enlargement she had experienced was primarily caused by the massive tumor burden within her uterus.

Dr. Lin, who became Ms. Liu’s chief physician, explained the treatment approach: “For early-stage endometrial cancer, surgical intervention with uterine removal remains the primary recommendation. However, when patients express a strong desire to preserve the uterus and their condition permits, conservative treatment options can be pursued. In advanced cases like Ms. Liu’s, we typically recommend comprehensive treatment combining multiple modalities. Given her advanced disease stage, her firm commitment to preserving her uterus, and her need to maintain work obligations, we designed a minimally invasive strategy using interventional therapy combined with seed implantation. This approach offers significantly lower trauma and reduced toxic side effects compared to traditional surgery.”

Advanced Minimally Invasive Treatment Methods

The treatment plan utilized two complementary minimally invasive technologies:

• Interventional Therapy: This technique requires only a 1-2 millimeter incision. Physicians use a catheter to deliver powerful anti-tumor medications directly to tumor tissues, allowing the drugs to attack cancer cells with precision while minimizing exposure to healthy surrounding tissues. The procedure is characterized by minimal trauma, rapid recovery, low toxicity to normal cells, and excellent treatment effectiveness.
• Radioactive Seed Implantation: This approach involves the direct placement of iodine-125 radioactive particles into tumor tissue or areas at risk of tumor invasion. These seeds emit continuous radiation specifically targeting tumor cells, effectively inactivating them while causing minimal or negligible damage to adjacent normal tissue.

Treatment Progress and Remarkable Results

Ms. Liu underwent six interventional therapy sessions and one radioactive seed implantation targeting her hepatic metastasis. The treatment timeline spanned from her initial April 2023 consultation through her ongoing follow-up care. A CT scan obtained on March 14, 2024, revealed remarkable progress: the massive thirteen-by-eleven-by-ten centimeter tumor that had previously occupied her uterus had completely disappeared. The liver metastasis that received seed implantation showed no remaining tumor activity and was successfully controlled. Most visibly, her previously distended abdomen had returned to normal proportions.

Navigating Challenges With Resilience

Though her treatment results exceeded expectations, Ms. Liu’s journey included significant obstacles that tested her commitment to recovery. She describes her initial feelings upon arrival: “When I first came to the hospital, my abdomen was extremely enlarged. I had attributed the weight gain to obesity and could barely comprehend how such a massive tumor had developed without my awareness. I experienced sadness and shock. However, the physicians were remarkably compassionate. They explained every aspect of my treatment in meticulous detail and offered continuous reassurance. Their dedication to my care immediately eased my anxiety, and I felt confident proceeding with my first interventional therapy session.”

The most challenging phase of her treatment occurred between May and December 2023. After her second hospitalization, Ms. Liu contracted chickenpox due to her weakened immune system compromised by cancer treatment. This complication prevented her from traveling back to China for continued therapy, resulting in a treatment interruption lasting over four months. During this extended pause, her condition deteriorated, with increased abdominal swelling and a return of her bloating symptoms. It was not until October that she could return to the hospital to resume treatment.

Upon re-evaluation, the medical team discovered that although the tumor itself had not enlarged, fluid accumulation within her uterine cavity was responsible for the abdominal distension. The team performed fluid drainage and intensified her treatment regimen. Ms. Liu remained hospitalized for more than a month during this intensive phase. Despite the emotional and physical toll of this setback, she maintained her resolve. “This period was genuinely difficult for me, but I had learned to accept my situation and place my complete trust in my medical team. I knew that with their guidance, I would overcome this challenge,” she reflects.

The Power of Compassionate Care

Ms. Liu emphasizes the exceptional quality of care she received throughout her treatment: “I am profoundly grateful for the dedication and compassion shown by every member of the medical and nursing staff. They treated me with genuine care, offered consistent encouragement, and showed genuine understanding of my emotional state. They recognized that I preferred quiet moments, so they would enter my room gently and speak in soft tones. My attending physician, Dr. Ma, possessed a wonderful sense of humor that frequently lifted my spirits and made difficult moments more bearable. The entire team provided me with invaluable emotional and medical support.” She notes that the psychological environment of the hospital never felt burdensome. Following each treatment cycle, she was able to return relatively quickly to her professional responsibilities. The primary challenge she faced was the geographic distance between Malaysia and the treatment center, which required significant travel time and coordination.

A Message of Hope for Others

When reflecting on her experience, Ms. Liu offers powerful advice for other patients confronting similar diagnoses: “Maintain your hope, commit yourself to your treatment plan, strive to live fully, and continue being yourself even as you battle illness.” She exemplifies these principles in her own life. Her persistence through multiple setbacks was ultimately rewarded with treatment success that surpassed even optimistic expectations. Today, her appearance and energy levels give no indication that she has endured serious illness. She has successfully returned to her professional role as a university admissions director, living proof that advanced cancer need not rob patients of their future or their identity.